{"id":53870,"date":"2023-02-13T19:04:12","date_gmt":"2023-02-13T18:04:12","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/access-initiative-strives-to-end-access-and-outcome-disparities-across-the-hematopoietic-cell-transplantation-and-cellular-therapy-ecosystem\/"},"modified":"2023-02-13T19:04:12","modified_gmt":"2023-02-13T18:04:12","slug":"access-initiative-strives-to-end-access-and-outcome-disparities-across-the-hematopoietic-cell-transplantation-and-cellular-therapy-ecosystem","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/access-initiative-strives-to-end-access-and-outcome-disparities-across-the-hematopoietic-cell-transplantation-and-cellular-therapy-ecosystem\/","title":{"rendered":"ACCESS Initiative Strives to End Access and Outcome Disparities Across The Hematopoietic Cell Transplantation and Cellular Therapy Ecosystem"},"content":{"rendered":"
\n

\nJeffery J. Auletta, MD, will Co-Chair the ASTCT Working Group with Stella M. Davies, MBBS, PhD, MRCP, Immediate Past President, ASTCT, Director, Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children\u2019s Hospital.<\/i>\n<\/p>\n

<\/a><\/p>\n

MINNEAPOLIS–(BUSINESS WIRE)–The National Marrow Donor Program\u00ae (NMDP)\/Be The Match\u00ae in partnership with the American Society for Transplantation and Cellular Therapy\u2122 (ASTCT) announced that Jeffery J. Auletta, MD, Senior Vice President, Patient Outcomes and Experience; Chief Scientific Officer, NMDP\/Be The Match and CIMBTR\u00ae (Center for International Blood and Marrow Transplant Research\u00ae); and Scientific Director, CIBMTR CRO Services, is co-chairing the Working Group for the ACCESS Initiative, a collaborative effort with ASTCT involving transplant centers as well as representatives from the private payer and federal agency sectors who have direct experience with hematopoietic cell transplantation (HCT) and cellular therapy (CT). The ASTCT-NMDP ACCESS Initiative addresses the recurring barriers to HCT\/CT that impact patient outcomes and strives to drive change in practice and policy throughout the industry ecosystem. Dr. Auletta is the Co-Chair of the ASTCT-NMDP Initiative along with Stella M. Davies, MBBS, PhD, MRCP, Immediate Past President, ASTCT and Director, Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children\u2019s Hospital.\n<\/p>\n

\n\u201cAs industry leaders, it\u2019s our responsibility to affect change to provide life-saving therapies to all eligible patients in need,\u201d said Dr. Auletta. \u201cResearch shows that a patient\u2019s race and socioeconomic status impact their access to HCT\/CT and similarly, their outcomes after receiving HCT\/CT. We recognize that these problems are chronic reflections of our healthcare system, which needs redirection and repair. The ACCESS Initiative aims to address these barriers and be a voice of change for more patients.\u201d\n<\/p>\n

\nThe ASTCT-NMDP ACCESS Initiative Working Group will be hosting a workshop on Saturday, February 18 at the Tandem Meetings, the combined annual meeting of the ASTCT and the CIBMTR. The group will address HCT disparities, provide an overview of the ACCESS committee\u2019s goals for the initiative and invite participation across the HCT\/CT ecosystem.\n<\/p>\n

\n\u201cDr. Auletta has been a key driver of this initiative from day one,\u201d said Davies. \u201cIt is only fitting that he continue his work as co-chair of the ACCESS Initiative Working Group and help lead the charge in implementing the findings from our inaugural workshop to address these systemic challenges in the healthcare industry.\u201d\n<\/p>\n

\nThe initiative will focus initially on three priority areas: awareness, poverty, and racial and ethnic inequity. The goals include:\n<\/p>\n